You are here:
budesonide (Budenofalk)
Advice
Following a full submission:
budesonide gastro-resistant capsule (Budenofalk®) is accepted for use within NHS Scotland.
Indication under review: symptomatic relief of chronic diarrhoea due to collagenous colitis.
budesonide (Budenofalk®) provides symptomatic improvement of diarrhoea associated with collagenous colitis compared with placebo.
Drug Details
| Drug Name: | budesonide (Budenofalk) |
|---|---|
| SMC Drug ID: | 828/12 |
| Manufacturer: | Dr Falk Pharma UK |
| Indication: | For the symptomatic relief of chronic diarrhoea due to collagenous colitis. |
| BNF Category: | |
| Sub Category: | 1.5 Chronic bowel disorders |
| Submission Type: | Full submission |
| Status: | Accepted |
| Date Advice Published: | 14 January 2013 |